Fluvac Innovator Triple-E FTThis page contains information on Fluvac Innovator Triple-E FT for veterinary use.
The information provided typically includes the following:
- Fluvac Innovator Triple-E FT Indications
- Warnings and cautions for Fluvac Innovator Triple-E FT
- Direction and dosage information for Fluvac Innovator Triple-E FT
Fluvac Innovator Triple-E FTThis treatment applies to the following species:
Eastern & Western & Venezuelan, Killed Virus
Fluvac Innovator Triple-E FT Indications
For intramuscular vaccination of healthy horses 10 months of age or older as an aid in the prevention of equine encephalomyelitis due to Eastern, Western and Venezuelan viruses, equine influenza due to type A2 viruses, and tetanus.
Fluvac Innovator Triple-E FT contains equine influenza virus A/equine-2/Kentucky/97 (H3N8)-American Lineage. Efficacy has been demonstrated by challenge with equine influenza virus A/equine-2/Ohio/03 (H3N8)-American Lineage.
Dosage and AdministrationHorses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually. Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make heavy exposure likely.
Fluvac Innovator Triple-E FT Caution
Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin and polymyxin B added as preservatives.
For Veterinary Use Only
Remove serial number and expiration date label and place on the animal’s medical chart.
U.S. Vet. License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Copyright © 2022 Animalytix LLC. Updated: 2021-11-29